SCHEMBL6028286

SCHEMBL6028286

O=C(O)c1ccn(NC(=O)c2ccccc2F)n1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P4HTM Q9NXG6 1/20 0.49
HPGD P15428 2/20 0.46
GAA P10253 1/20 0.45
KMT2A Q03164 4/20 0.44
MEN1 O00255 2/20 0.44
TDP1 Q9NUW8 1/20 0.44
KAT6A Q92794 1/20 0.43
NPC1 O15118 4/20 0.43
ALDH1A1 P00352 1/20 0.43
MAPT P10636 1/20 0.43
RAB9A P51151 3/20 0.42
HTT P42858 2/20 0.42
GRM5 P41594 1/20 0.41
LMNA P02545 1/20 0.41
POLB P06746 1/20 0.41
HSD17B10 Q99714 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C9 P11712 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL954862 0.80 CYP3A4 (0.45) P4HTMHPGDGAAKMT2AMEN1
SCHEMBL6027891 0.78 KAT6A (0.50) P4HTMGAAKMT2AKAT6ANPC1
SCHEMBL3937476 0.72 JAK2 (0.41) HPGDGAAKMT2AMEN1NPC1
SCHEMBL3936139 0.71 MEN1 (0.48) HPGDGAAKMT2AMEN1ALDH1A1
SCHEMBL10917437 0.70 F2 (0.42) P4HTMGAAKMT2AMEN1TDP1
SCHEMBL4703954 0.69 GRM5 (0.53) P4HTMHPGDKMT2AMEN1TDP1
SCHEMBL5784304 0.69 KMT2A (0.53) HPGDKMT2AMEN1TDP1NPC1
SCHEMBL2802508 0.68 MME (0.38) GAAALDH1A1MAPTHTTLMNA
SCHEMBL4701525 0.68 GRM5 (0.72) P4HTMKMT2AMAPTGRM5POLB
SCHEMBL28190255 0.67 GAA (0.64) HPGDGAAKMT2AMEN1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1651612-A1 3,4-DISUBSTITUTED 1H-PYRAZOLE COMPOUNDS AND THEIR USE AS CYCLIN DEPENDENT KINASES (CDK) AND GLYCOGEN SYNTHASE KINASE-3 (GSK-3) MODULATORS Astex Therapeutics Limited (GB) 2006-05-03 EP disclosed
WO-2005012256-A1 3, 4-DISUBSTITUTED 1H-PYRAZOLE COMPOUNDS AND THEIR USE AS CYCLIN DEPENDENT KINASES (CDK) AND GLYCOGEN SYNTHASE KINASE-3 (GSK-3) MODULATORS ASTEX THERAPEUTICS LIMITED (GB) 2005-02-10 WO disclosed